Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Dentsply Sirona (XRAY) Cash from Financing Activities (2016 - 2025)

Dentsply Sirona's Cash from Financing Activities history spans 16 years, with the latest figure at -$99.0 million for Q4 2025.

For the quarter ending Q4 2025, Cash from Financing Activities fell 160.53% year-over-year to -$99.0 million, compared with a TTM value of -$80.0 million through Dec 2025, up 73.51%, and an annual FY2025 reading of -$80.0 million, up 73.51% over the prior year.
Cash from Financing Activities for Q4 2025 was -$99.0 million at Dentsply Sirona, down from -$36.0 million in the prior quarter.
The five-year high for Cash from Financing Activities was $123.0 million in Q1 2025, with the low at -$171.0 million in Q2 2024.
Average Cash from Financing Activities over 4 years is -$63.6 million, with a median of -$73.5 million recorded in 2024.
Year-over-year, Cash from Financing Activities tumbled 1716.67% in 2023 and then soared 978.57% in 2025.
Tracing XRAY's Cash from Financing Activities over 4 years: stood at -$161.0 million in 2022, then increased by 20.5% to -$128.0 million in 2023, then surged by 70.31% to -$38.0 million in 2024, then tumbled by 160.53% to -$99.0 million in 2025.
Per Business Quant, the three most recent readings for XRAY's Cash from Financing Activities are -$99.0 million (Q4 2025), -$36.0 million (Q3 2025), and -$68.0 million (Q2 2025).